Marc-André Roy, MD, MSc

home / authors / marc-andré-roy-md-msc

Articles

Treating Comorbid Anxiety Disorders in Patients With Schizophrenia: A New Pathway

Amélie M. Achim, PhD;Stephanie Sutliff, MSc;Marc-André Roy, MD, MSc

January 30th 2015

Identifying comorbid anxiety disorders as potential treatment targets may contribute to more positive outcomes for patients with schizophrenia. Details here.

Latest Updated Articles

Published: April 16th 2021 | Updated: July 15th 2025

PsychQuiz: Tardive Dyskinesia Risk Factors

Published: March 19th 2021 | Updated: July 15th 2025

Mini Quiz: Treatment for Pedophilia?

Published: July 12th 2025 | Updated: July 15th 2025

Toward a Muscarinic Agent Solution for the Presynaptic Dopamine Problem in Schizophrenia

Published: July 12th 2025 | Updated: July 15th 2025

Treatment-Resistant Depression and Well-Rounded Care, With Alejandro Alva at Southern California Psychiatry

Published: March 11th 2020 | Updated: July 15th 2025

Mini Quiz: Coronavirus Outbreak and Mental Illness

Published: July 12th 2025 | Updated: July 15th 2025

Well-Rounded Examination for Treatment of Tardive Dyskinesia

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777